who offers semaglutide for weight loss Injections in Pueblo, CO Semaglutide GLP-1 vs Tirzepatide for

discontinued CJC-1295 (DAC) Not FDA-approved Feature Phase III Trial Data Tesamorelin Yes (n=816 pooled) Sermorelin No adult Phase III VAT datasets CJC-1295 (DAC) No Feature Visceral Fat Reduction Tesamorelin 15-20% at 26 weeks Sermorelin Not formally studied in RCTs CJC-1295 (DAC) Not formally studied in RCTs Feature Liver Fat Reduction Tesamorelin 32% at 12 months (NAFLD trial) Sermorelin Not studied CJC-1295 (DAC) Not studied Feature Typical Research Dose Tesamorelin 2 mg daily Sermorelin 200-300 mcg nightly CJC-1295 (DAC) 1-2 mg weekly Feature Unique Advantage Tesamorelin Only FDA-approved GHRH with deepest trial evidence Sermorelin Longest historical track record CJC-1295 (DAC) Weekly dosing convenience Tesamorelin is the only GHRH peptide with active FDA approval and validated Phase III visceral-fat data

Frequently asked questions Yes, weight loss is possible with insulin resistance, but it may require a more targeted approach than standard calorie restriction

Skin + Cellular Renewal Anti-Aging Dual-action blend for visible skin rejuvenation and cellular anti-aging

SIDE NOTE: Its important to note here that Felix does not offer compound semaglutide

Personalization Personalized Care : Programs like Lilly Direct and Noom Med offer personalized plans that include telehealth consultations and regular follow-ups